By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celator Pharmaceuticals, Inc. 

303B College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-243-0123 Fax: 609-243-0202


SEARCH JOBS








Company News
Celator Pharmaceuticals, Inc. To Present At The Rodman & Renshaw 17th Annual Global Investment Conference 9/1/2015 7:03:40 AM
Celator Pharmaceuticals, Inc. Appoints Michael R. Dougherty As Executive Chairman Of Board Of Directors 8/24/2015 6:32:43 AM
Celator Pharmaceuticals, Inc. Announces Second Quarter 2015 Financial Results And Business Update 8/12/2015 7:32:25 AM
Celator Pharmaceuticals, Inc. To Report Second Quarter 2015 Financial Results On August 11, 2015 8/4/2015 8:04:45 AM
Celator Pharmaceuticals, Inc. To Present On Fixed-Ratio Nanomedicines At The 2015 Controlled Release Society Annual Meeting 7/28/2015 11:55:53 AM
Celator Pharmaceuticals, Inc. Announces Start Of Clinical Study Of CPX-351 In Acute Myeloid Leukemia Patients At High Risk For Induction Mortality 7/14/2015 7:00:50 AM
Celator Pharmaceuticals, Inc. To Host Analyst And Investor Day On July 16, 2015 7/7/2015 7:41:17 AM
Celator Pharmaceuticals, Inc. Release: The Leukemia & Lymphoma Society Accelerates Milestone Payment Associated With The Phase 3 Study Of CPX-351 In High Risk (Secondary) AML 6/29/2015 8:45:25 AM
The Leukemia & Lymphoma Society Applauds Encouraging Data Released By Celator Pharmaceuticals, Inc. From Its Phase 3 Clinical Study Of CPX-351 For High-Risk Acute Myeloid Leukemia Patients 6/24/2015 9:42:50 AM
Celator Pharmaceuticals, Inc. Announces Positive Induction Response Results From Phase 3 Study Of CPX-351 In Patients With High-Risk (Secondary) Acute Myeloid Leukemia 6/24/2015 6:35:48 AM
12345678910...
//-->